[Activity Report] Submission of recommendations to Public Comment on the “Draft Order of the Pandemic Influenza and New Infection Diseases Preparedness and Response Council”
date : 3/25/2021
Tags: AMR
On March 25, 2021, the Health and Global Policy Institute submitted its opinions to a public comment on the “Draft Order of the Pandemic Influenza and New Infection Diseases Preparedness and Response Council.”
A summary of the comments is as follows. Please see the PDF file found here for details (information available only in Japanese).
Antimicrobial resistance (AMR) occurs when the organisms that cause infectious diseases grow resistant to treatment. This problem can lead to otherwise preventable deaths due to infectious diseases. It is estimated that 8,000 people die annually from AMR-related causes in Japan, which is more than twice the number of annual traffic deaths. This number is comparable to the 8,835 deaths caused by COVID-19 so far in Japan (as of March 22, 2021).
Bold policies on AMR are urgently needed to prevent the loss of countless lives in the future. Based on the strong leadership of the government, Japan enacted a National Action Plan on Antimicrobial Resistance in April 2016, which greatly contributed to the promotion of AMR measures domestically. Even though it is about time for the next action plan to be announced, there is no clear date for its release despite the many existing issues related to AMR.
The COVID-19 pandemic has shown just how important it is to prepare for infectious disease problems ahead of time. AMR too is an infectious disease crisis. A Subcommittee on AMR should be established within the Government to consider AMR measures including the formulation of the next action plan.
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
Featured Posts
-
2024-04-12
[Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
-
2024-04-16
[Activity Report] HGPI Child Health Project Selected to Implement FY2024 Nippon Foundation Grant Program, “Establishing a Skill Development Program and Collaborative Network for Improving Mental Health for Students with Intellectual Disabilities” (April 15, 2024)
-
2024-04-18
[Event Report] NCDs-related Cross-project Meeting: The 2nd Meeting on Non-Communicable Disease in Hokkaido and Tohoku (March 15, 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)